{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:55:07Z","timestamp":1777874107019,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA261787"],"award-info":[{"award-number":["T32CA261787"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpainsymman.2025.02.010","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T01:28:24Z","timestamp":1739669304000},"page":"e330-e336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Providers' Barriers to Buprenorphine Prescribing for Cancer-Related Pain"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-8290","authenticated-orcid":false,"given":"Katarina E.","family":"AuBuchon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2490-0260","authenticated-orcid":false,"given":"KerriAnn M.","family":"Boanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhitha","family":"Muthineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4040-890X","authenticated-orcid":false,"given":"Melody A.","family":"Emenyonu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0810","authenticated-orcid":false,"given":"Hannah","family":"Arem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3092-1877","authenticated-orcid":false,"given":"Kristen","family":"McElreath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0002","unstructured":"Anekar AA, Hendrix JM and Cascella M, WHO analgesic ladder, 2023, StatPearls Publishing, Treasure Island, FL.https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554435\/. Accessed December 7, 2023."},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0003","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/j.jpainsymman.2023.06.022","article-title":"Should buprenorphine Be considered a first-line opioid for the treatment of moderate to severe cancer pain?","volume":"66","author":"Chwistek","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis","year":"2012","journal-title":"J Support Oncol"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","article-title":"Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u2018real life\u2019 trial on the variability of response to opioids","volume":"27","author":"Corli","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0006","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2147\/DDDT.S141007","article-title":"A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients","volume":"11","author":"Nosek","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0007","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpainsymman.2007.09.011","article-title":"Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain","volume":"36","author":"Poulain","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/jpm.2022.0399","article-title":"Top ten tips palliative care clinicians should know about Buprenorphine","volume":"26","author":"Neale","year":"2023","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0009","first-page":"1","article-title":"Buprenorphine for treating cancer pain","volume":"2015","author":"Schmidt-Hansen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0010","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00432-013-1487-0","article-title":"Safety and efficacy of transdermal buprenorphine for the relief of cancer pain","volume":"139","author":"Naing","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0011","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1185\/03007990902920731","article-title":"The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus","volume":"25","author":"Pergolizzi","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1634\/theoncologist.2014-0276","article-title":"How well do medical oncologists manage chronic cancer pain? A national survey","volume":"20","author":"Breuer","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0013","first-page":"157","article-title":"The management of cancer pain","volume":"61","author":"Paice","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0014","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13187-018-1433-6","article-title":"Cancer pain management among oncology nurses: knowledge, attitude, related factors, and clinical recommendations: a systematic review","volume":"34","author":"Bouya","year":"2019","journal-title":"J Cancer Educ"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1136430","article-title":"A survey of knowledge and barriers of healthcare professionals toward opioid analgesics in cancer pain management","volume":"2022","author":"Ayoub","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0016","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/bjon.2024.33.5.S4","article-title":"Exploring health professionals\u2019 knowledge of cancer-related pain: a scoping review","volume":"33","author":"Galligan","year":"2024","journal-title":"Br J Nurs"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0017","doi-asserted-by":"crossref","first-page":"e1030","DOI":"10.1200\/OP.20.01041","article-title":"This is a different patient population: opioid prescribing challenges for patients With cancer-related pain","volume":"17","author":"Schenker","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0018","doi-asserted-by":"crossref","first-page":"37517","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol Res"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0019","doi-asserted-by":"crossref","first-page":"E182","DOI":"10.1097\/j.pain.0000000000002343","article-title":"Framework for opioid stigma in cancer pain","volume":"163","author":"Bulls","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-082033","article-title":"Identifying provider, patient and practice factors that shape long-term opioid prescribing for cancer pain: a qualitative study of American and Australian providers","volume":"14","author":"Fereydooni","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-684X-12-32","article-title":"A qualitative study examining the sustainability of shared care in the delivery of palliative care services in the community","volume":"12","author":"Demiglio","year":"2013","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0022","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12904-020-00556-7","article-title":"Palliative care utilization in oncology and hemato-oncology: a systematic review of cognitive barriers and facilitators from the perspective of healthcare professionals, adult patients, and their families","volume":"19","author":"Bennardi","year":"2020","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpainsymman.2025.02.010_bib0023","unstructured":"Davis, Corey. Appendix B: State-by-state summary of opioid prescribing regulations and guidelines. Arizona Department of Health Services. Retrieved from:https:\/\/www.azdhs.gov\/documents\/prevention\/womens-childrens-health\/injury-prevention\/opioid-prevention\/appendix-b-state-by-state-summary.pdf. Accessed February 24, 2025."}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392425000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:03:46Z","timestamp":1777575826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392425000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0885392425000533"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.02.010","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Providers' Barriers to Buprenorphine Prescribing for Cancer-Related Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2025.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}